These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23448490)

  • 1. Insulin resistance, oxidative stress and cardiovascular complications: role of sirtuins.
    Bagul PK; Banerjee SK
    Curr Pharm Des; 2013; 19(32):5663-77. PubMed ID: 23448490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in insulin-resistant conditions: cardiovascular implications.
    Stump CS; Clark SE; Sowers JR
    Treat Endocrinol; 2005; 4(6):343-51. PubMed ID: 16318400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes.
    Patel TP; Rawal K; Bagchi AK; Akolkar G; Bernardes N; Dias DDS; Gupta S; Singal PK
    Heart Fail Rev; 2016 Jan; 21(1):11-23. PubMed ID: 26542377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins.
    Sanz RL; Inserra F; García Menéndez S; Mazzei L; Ferder L; Manucha W
    Curr Hypertens Rep; 2023 Jun; 25(6):91-106. PubMed ID: 37052810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirtuins: To Be or Not To Be in Diabetic Cardiomyopathy.
    Palomer X; Aguilar-Recarte D; García R; Nistal JF; Vázquez-Carrera M
    Trends Mol Med; 2021 Jun; 27(6):554-571. PubMed ID: 33839024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.
    Ceriello A; Motz E
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):816-23. PubMed ID: 14976002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Mitochondrial Sirtuins in Mitochondrial Function, Redox Homeostasis, Insulin Resistance and Type 2 Diabetes.
    Wang CH; Wei YH
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian Clock and Sirtuins in Diabetic Lung: A Mechanistic Perspective.
    Zhou S; Dai YM; Zeng XF; Chen HZ
    Front Endocrinol (Lausanne); 2020; 11():173. PubMed ID: 32308644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of sirtuins in the regulatin of oxidative stress during the progress and therapy of type 2 diabetes mellitus.
    Chen J; Wang Q; Li R; Li Z; Jiang Q; Yan F; Ye J
    Life Sci; 2023 Nov; 333():122187. PubMed ID: 37858715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.
    Fiorentino TV; Prioletta A; Zuo P; Folli F
    Curr Pharm Des; 2013; 19(32):5695-703. PubMed ID: 23448484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms for oxidative stress in diabetic cardiovascular disease.
    Pennathur S; Heinecke JW
    Antioxid Redox Signal; 2007 Jul; 9(7):955-69. PubMed ID: 17508917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirtuins, aging, and cardiovascular risks.
    Favero G; Franceschetti L; Rodella LF; Rezzani R
    Age (Dordr); 2015 Aug; 37(4):9804. PubMed ID: 26099749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of Insulin Resistance, Endothelial Dysfunction and Lifestyle Changes in the Development of Cardiovascular Disease in Diabetic Patients.
    Sun D; Man W; Zhang L
    Curr Drug Targets; 2017; 18(15):1792-1799. PubMed ID: 27425648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox Homeostasis in Cardiovascular Disease: The Role of Mitochondrial Sirtuins.
    Zullo A; Guida R; Sciarrillo R; Mancini FP
    Front Endocrinol (Lausanne); 2022; 13():858330. PubMed ID: 35370975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macronutrient specific postprandial oxidative stress: relevance to the development of insulin resistance.
    Fisher-Wellman K; Bloomer RJ
    Curr Diabetes Rev; 2009 Nov; 5(4):228-38. PubMed ID: 19604133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.
    Xu YJ; Tappia PS; Neki NS; Dhalla NS
    Heart Fail Rev; 2014 Jan; 19(1):113-21. PubMed ID: 23436032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Caveolin-1 in Diabetes and Its Complications.
    Haddad D; Al Madhoun A; Nizam R; Al-Mulla F
    Oxid Med Cell Longev; 2020; 2020():9761539. PubMed ID: 32082483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and antioxidant treatment in diabetes.
    Scott JA; King GL
    Ann N Y Acad Sci; 2004 Dec; 1031():204-13. PubMed ID: 15753146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study.
    Meigs JB; Larson MG; Fox CS; Keaney JF; Vasan RS; Benjamin EJ
    Diabetes Care; 2007 Oct; 30(10):2529-35. PubMed ID: 17586736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.